Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, PR China.

Nearly a year after alarms about CAR T-cell therapies possibly causing secondary lymphomas, studies suggest that genetic predisposition—not vector integration—are likely the primary cause of these ...

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: Marc Ladanyi, Department of Pathology and Laboratory Medicine, Memorial ...

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...

Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

M. Piffoux and J. Jacquemin contributed equally to this article. O. Tredan and Y. Drouet contributed equally to this article.

The Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts. *Corresponding Author: Andrew J. Aguirre, Dana-Farber ...

Center of Excellence for Leukemia Studies, St. Jude Children’s Research Hospital, Memphis, Tennessee.

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. *Corresponding Author: Max S. Wicha, Department of Internal Medicine, University of Michigan–Ann Arbor, 2800 Plymouth Road ...

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. M.R.